Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.



<ul>
<li>Mizuho analyst Dan Dolev initiated coverage on PayPay Corp – ADR (NASDAQ:PAYP) with an Outperform rating and announced a price target of $26. PayPay shares closed at $21.02 on Thursday. See how other analysts view this stock.</li>



<li>Citizens analyst Jason Butler initiated coverage on Avalo Therapeutics Inc (NASDAQ:AVTX) with a Market Outperform rating and announced a price target of $52. Avalo Therapeutics shares closed at $17.76 on Thursday. See how other analysts view this stock.</li>



<li>HC Wainwright &amp; Co. analyst Heiko Ihle initiated coverage on Atlas Critical Minerals Corp (NASDAQ:ATCX) with a Buy rating and announced a price target of $13.75. Atlas Critical Minerals shares closed at $5.69 on Thursday. See how other analysts view this stock.</li>



<li>Wells Fargo analyst Colin Langan initiated coverage on Versigent PLC (NYSE:VGNT) with an Overweight rating and announced a price target of $35. Versigent shares closed at $28.10 on Thursday. See how other analysts view this stock.</li>



<li>Benchmark analyst Mark Palmer initiated coverage on PayPay Corp – ADR (NASDAQ:PAYP) with a Buy rating and announced a price target of $31. PayPay shares closed at $21.02 on Thursday. See how other analysts view this stock.</li>
</ul>



Considering buying AVTX stock? Here’s what analysts think: 



<figure class="wp-block-image size-large is-resized"><img width="1024" height="505" src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/06084828/image-84-1024x505.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/06084828/image-84-1024x505.png"/></figure>



Photo via Shutterstock

ARKG

TMED

AVTX

Wall Street analysts have initiated coverage on several stocks, including Avalo Therapeutics Inc (NASDAQ:AVTX), which received a Market Outperform rating and a price target of $52 from Citizens analyst Jason Butler. Avalo shares closed at $17.76. Other notable initiations include PayPay Corp (NASDAQ:PAYP) with an Outperform rating and a price target of $26, and Atlas Critical Minerals Corp (NASDAQ:ATCX) with a Buy rating and a price target of $13.75. Analysts have changed their outlooks on various stocks, reflecting a mix of upgrades and downgrades.

benzinga_article

Ark Genomic Revolution ETF

T. Rowe Price Health Care ETF

Avalo Therapeutics

Blackrock Future Health ETF

Invesco Biotechnology & Genome ETF

Health Care Select Sector SPDR

iShares Biotechnology ETF

ALPS Medical Breakthrough

iShares US Pharma

First Trust NYSE Arca Biotech Index Fd

Atlas Critical Minerals

Direxion S&P Biotech Bull 3X

VG Health

Invesco Nasdaq Biotechnology ETF

VanEck Biotech ETF

PayPay

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday